Announcements
        23 July 2025
        Cancers | Highly Cited Special Issues in 2024 in the “Clinical Research of Cancer” Section
    
            
    
    
    
      
    
  
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
    
    
    We are delighted to share some Highly Cited Special Issues in 2024 on Clinical Research of Cancer in Cancers (ISSN: 2072-6694).
The list of Highly Cited Special Issues can be viewed below:
| 
 “Clinical and Pathologic Response to Therapy in Gastrointestinal Oncology”  | 
 “Stereotactic Body Radiation and Stereotactic Ablative Radiotherapy Therapy for Cancers”  | 
| 
 
  | 
 
  | 
| 
 “Identification of the Targets to Overcome Clinical Problems in Bladder Cancer”  | 
 “Prognostic Factors in Urologic Cancers—Assessment and Integration into Clinical Care”  | 
| 
 
  | 
 
  | 
| 
 “Clinical and Translational Updates in Renal Cell Carcinoma”  | 
 “Gastrointestinal Oncology: Clinical Management”  | 
| 
 
  | 
 
  | 
Cancers Editorial Office